| Q93230247 | Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005-2014 |
| Q34721426 | Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study |
| Q40322219 | Comparing serum microRNA levels of acute herpes zoster patients with those of postherpetic neuralgia patients |
| Q49793596 | Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials |
| Q58111989 | Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review |
| Q47136517 | Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients |
| Q36956756 | Diagnosing and managing postherpetic neuralgia |
| Q37206825 | Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. |
| Q37539287 | Evaluation of microRNA Expression in Patients with Herpes Zoster |
| Q35498396 | Evaluation of the economic burden of Herpes Zoster (HZ) infection |
| Q89786056 | Fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an HIV-infected patient: a case report |
| Q26770662 | Herpes Zoster: the rationale for the introduction of vaccination in Italy |
| Q57482005 | Herpes zoster in the context of varicella vaccination - An equation with several variables |
| Q35008196 | Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). |
| Q36136301 | Identification of an indol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor |
| Q47630850 | Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster |
| Q37669420 | Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study. |
| Q64262221 | Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged ≥50 years: A prospective study |
| Q37263293 | Pathogenesis and current approaches to control of varicella-zoster virus infections |
| Q34592021 | Population-based study of the epidemiology of herpes zoster in Korea. |
| Q38734753 | Post-herpetic Neuralgia: a Review. |
| Q40163840 | Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity |
| Q55325844 | Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm. |
| Q26748712 | Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review |
| Q26998625 | Reducing the burden of Herpes Zoster in Italy |
| Q90402301 | Short-term efficacy and safety of prednisone in herpes zoster and the effects on IL-6 and IL-10 |
| Q92829450 | The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial |
| Q92814832 | The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy |
| Q36041839 | Varicella-zoster virus susceptibility and primary healthcare consultations in Norway |